2017
DOI: 10.1164/rccm.201608-1675pp
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
184
1
16

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 193 publications
(217 citation statements)
references
References 91 publications
(124 reference statements)
3
184
1
16
Order By: Relevance
“…There are basically 2 views: one is that CHP is defined by time since the appearance of symptoms (variously described in the literature as greater than 3 months, 4 months, or 1 year) and/or the pattern of disease presentation (''recurrent,'' ''insidious,'' versus ''acute''); the other is that CHP is defined only by the presence of fibrosis either on imaging or from biopsy (reviewed in Salisbury et al 1 and Spagnolo et al 13 ). In our view, the evidence is clear (see Relationship of Pathologic Findings in CHP to Prognosis below) that the presence of fibrosis is associated with a considerably worse prognosis compared with patients with HP who do not have fibrosis (under this definition, the latter are labeled as having acute or subacute CHP, depending on presentation), and we will use CHP here to indicate only HP cases with fibrosis.…”
Section: Definition Of Chpmentioning
confidence: 99%
See 2 more Smart Citations
“…There are basically 2 views: one is that CHP is defined by time since the appearance of symptoms (variously described in the literature as greater than 3 months, 4 months, or 1 year) and/or the pattern of disease presentation (''recurrent,'' ''insidious,'' versus ''acute''); the other is that CHP is defined only by the presence of fibrosis either on imaging or from biopsy (reviewed in Salisbury et al 1 and Spagnolo et al 13 ). In our view, the evidence is clear (see Relationship of Pathologic Findings in CHP to Prognosis below) that the presence of fibrosis is associated with a considerably worse prognosis compared with patients with HP who do not have fibrosis (under this definition, the latter are labeled as having acute or subacute CHP, depending on presentation), and we will use CHP here to indicate only HP cases with fibrosis.…”
Section: Definition Of Chpmentioning
confidence: 99%
“…1 In current practice, whether a patient has CHP is a common, multidisciplinary discussion, and one about which there is often considerable disagreement. In a formal study, Walsh et al 2 asked 7 experienced multidisciplinary discussion groups, comprising clinicians, radiologists, and pathologists, to review the same 70 cases and examined the level of agreement.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…However, making the diagnosis of HP remains challenging due to variability of clinical findings and lack of consensus criteria [1517]. A history of exposure has been shown to be the most powerful determinant of an HP diagnosis, which requires a thoughtful approach that may span multiple patient encounters [18, 19].…”
Section: Introductionmentioning
confidence: 99%
“…Two recent papers reached different conclusion in this regard [15, 23]. However, in patients without a clearly identifiable fibrogenic antigen or an HRCT that is nondiagnostic, additional invasive testing is required [24].…”
Section: Introductionmentioning
confidence: 99%